FDA NDC Directory · JSON-LD · Markdown

Vyndamax

NDC 0069-8730 · HUMAN PRESCRIPTION DRUG · CAPSULE, LIQUID FILLED

Generic nametafamidis
Labeler / ManufacturerPfizer Laboratories Div Pfizer Inc
Marketing categoryNew Drug Application (innovator) · App NDA212161
Dosage form / routeCAPSULE, LIQUID FILLED · ORAL
Active ingredientsTAFAMIDIS (61 mg/1)
Marketing started20190827
Package count1

External sources

Source: openFDA. Public-domain (CC0).